Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
NEPHROS INC shareholders approved Ratification of the appointment of Baker Tilly US, LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023 at the 2023-06-01 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2023-06-01
Exact text from the filing
Stockholders ratified the appointment of Baker Tilly US, LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
NEPHROS INC shareholders approved Election of Director at the 2023-06-01 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2023-06-01
Exact text from the filing
Stockholders elected to the Company’s Board of Directors one nominee, Joseph Harris, to serve a three-year term expiring in 2026
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
NEPHROS INC shareholders approved Approval of the compensation of the Company’s named executive officers on an advisory (non-binding) basis at the 2023-06-01 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2023-06-01
Exact text from the filing
Stockholders approved the compensation of the Company’s named executive officers on an advisory (non-binding) basis
View on SEC.gov